{
  "docId": "019de072-a701-779d-b9c1-29622b36dd41",
  "docSlug": "f2c95dae10c304072442cd11deed84ec",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 53 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 7,
  "pageCount": 53,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses checkmarks to indicate completed items and empty circles for pending items.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-a701-779d-b9c1-29622b36dd41/7",
  "deckHref": "/decks/019de072-a701-779d-b9c1-29622b36dd41",
  "deckJsonHref": "/decks/019de072-a701-779d-b9c1-29622b36dd41.json",
  "deckAnchorHref": "/decks/019de072-a701-779d-b9c1-29622b36dd41#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.92,
        "x": 0.04,
        "y": 0.82
      },
      "kind": "disclaimer",
      "text": "This presentation does not constitute an offer to sell or the solicitation of an offer to buy any securities.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab0c6ae1-972f-40ac-b4b7-643cf155abba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.92,
        "x": 0.04,
        "y": 0.18
      },
      "kind": "list",
      "text": "Complete financial segmentation of Bausch + Lomb and Solta Medical\nAppoint leadership of Bausch Pharma, Bausch + Lomb and Solta Medical\nSignificant debt paydown of ~$2B for Bausch Health since announcement of strategic alternatives process\nSubstantially complete in our preparations and planning for the Bausch + Lomb IPO\nSubstantially complete in our preparations and planning for the Solta Medical IPO\nRaised new debt to refinance certain existing debt and announced refinancing of existing BHC credit facilities to facilitate B+L IPO and full separation\nAnnounced public filing of S-1s relating to the proposed IPOs of Bausch + Lomb and Solta Medical\nClosed credit facilities for Bausch + Lomb including $2.5B term loan B and $500M revolving facility to facilitate separation from Bausch Health\nCompleted Bausch + Lomb IPO\nLaunch Solta Medical IPO subject to market conditions\nBausch + Lomb spinoff (distribution of remaining shares to existing Bausch Health shareholders) following the expiry of customary lock-ups related to the B+L IPO, achievement of our target net leverage ratios and subject to market conditions",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "25761b55-1fd9-42f0-8386-fc4ea3739763",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.7,
        "x": 0.26,
        "y": 0.89
      },
      "kind": "source-note",
      "text": "1. See Slide 1 for further information on forward-looking statements.\n2. Subject to market conditions, other factors and regulatory, stock exchange and other approvals.\n3. Subject to receipt of applicable shareholder and other necessary approvals and factors.\n4. There can be no assurance that the refinancing of our existing credit facilities will be consummated on the on anticipated terms, or at all.\n5. BAUSCH+LOMB IPO priced on May 5, 2022, and is scheduled to close on May 10, 2022, subject to customary closing conditions. BAUSCH+LOMB debt raise is subject to the completion of the BAUSCH+LOMB IPO.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ed9f234f-a90c-4cc4-b1f1-8fd740b9ebee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.17,
        "y": 0.04
      },
      "kind": "title",
      "text": "Executing Strategic Alternatives to Drive Shareholder Value",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "05ee060e-91f1-4edd-90cf-9058723fe3c0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 7,
      "from": 7,
      "beatId": "d0810987-9c36-406b-adbe-9c737e828443",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "Roadmap slide",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}